The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

NCT02673554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: GIP Bolus
DRUG: GIP Clamp
PROCEDURE: Oral glucose tolerance test (OGTT)
PROCEDURE: hyperglycemic clamp

Sponsor

Diabeteszentrum Bad Lauterberg im Harz